Drug
HL 10
HL 10: highest development phase Phase 3, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| HL 10 NCT00742482 | Phase 3 | Acute Lung Injury |
Latest
No recent events.
Follow HL 10 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.